The Alliance’s blog offers a personal, inside look at our activities and perspectives on a range of timely issues. We encourage your feedback.


Author: Noel Lloyd

Date: June 12th, 2015

The 21st Century Cures Act represents a positive change in how American biomedical research will be conducted and streamlines the processes intended to deliver new medical cures and treatment to patients. Currently being considered for a vote on the floor of the U.S. House of Representatives later this month, the bill, also known as H.R. 6, has been a bipartisan effort, passing out of the House Energy & Commerce Committee in May by a vote of 51-0.

The pace of scientific discovery since the turn of the century has accelerated at a speed that was not possible a generation ago.  This bill was developed after the realization by leaders in Congress that the current health care innovation infrastructure needed improvement to accommodate these advances in science.  H.R. 6 removes barriers to research collaboration, helps modernize clinical trials, facilitates patient input into the research and development process, encourages more young scientists to pursue careers in research, and authorizes an additional $10 billion for research funding at the National Institutes of Health.

This bill has received an outpouring of support not only in Congress, but from patients, advocacy organizations, including the Alliance for Aging Research, news outlets, and leading researchers. 

We encourage you to show your support for the 21st Century Cures Act by contacting your congressperson and letting them know you want their vote on this critical legislation.  You can follow and participate in the conversation around 21st Century Cures on Twitter using the #cures2015.

A Tribute to a Great Scientist

Author: Dan Perry

Date: March 11th, 2008

FDA Needs More Funding to Fulfill Its Mission

Author: Cynthia Bens

Date: March 18th, 2008

Spending or Investing? -- The Silver Book & Innovation

Author: Lindsay Clarke

Date: March 26th, 2008

Preventing the Flu: A Q & A with Dr. William Schaffner

Author: Noel Lloyd

Date: December 4th, 2017

A Recap of the Clinical Trials for Alzheimer’s Disease Conference

Author: Phyllis Greenberger

Date: December 1st, 2017

An Update on the Clinical Trials for Alzheimer’s Disease Conference

Author: Noel Lloyd

Date: November 7th, 2017

Living Longer & Loving It

Sign up for our electronic newsletter Living Longer & Loving It